Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Member Conflict Review, Program Announcement (PA) 07-318, 3049-3050 [E9-870]

Download as PDF 3049 Federal Register / Vol. 74, No. 11 / Friday, January 16, 2009 / Notices HUD-subsidized housing that has either been rehabilitated in a green (e.g., case) or a traditional manner (e.g., control) from study sites across the United States. Pregnant women and children with asthma (ages 7–12 years) will donate blood samples (for assessment of allergy) and urine samples (for assessment of pesticide and VOC exposures). The children with asthma (ages 7–12 years) will be also tested for lung function and lung inflammatory markers. Questionnaires regarding home characteristics and respiratory symptoms will be administered at 3month intervals over a 2-year period. Of the pregnant women enrolled, neurodevelopment of their infant will be tested at ages 1 week and 6 months. Environmental sampling of the air and dust in the participants’ homes will be conducted over a 2 year period (once in the home before rehabilitation, and then at four time points after rehabilitation has been completed: Baseline, 6 months, 12 months, and 24 months). Environmental sampling includes measurements of air exchange rate, pesticides, VOCs, indoor allergens, fungi, temperature, humidity, and particulate matter. There is no cost to respondents other than their time. ESTIMATED ANNUALIZED BURDEN HOURS Respondents Mothers of enrolled children. Number of responses per respondent Number of respondents Forms Average burden per response (in hours) Total burden (in hours) Screening questionnaire ............................ 800 1 5/60 067 Baseline Questionnaire (Home Characteristics). Baseline Questionnaire (for Mother) ......... Baseline Questionnaire (for Children 0–6 years). Baseline Questionnaire (for Children 7–12 with asthma). 3, 9, 15, and 18-month Phone contact ..... 6, 12, and 24-month Follow-up Questionnaire (for environment). 6, 12, and 24-month Follow-up Questionnaire (for women). 6, 12, and 24-month Follow-up Questionnaire (for children 0–6). 6, 12, and 24-month Follow-up Questionnaire (for asthmatic child 7–12). Screening questionnaire ............................ Baseline Questionnaire (Home Characteristics). Baseline Questionnaire (for Pregnant woman). 3, 9, 15, and 18-month Phone contact ..... 6, 12, and 24-month Follow-up Questionnaire (for environment). 6, 12, and 24-month Follow-up Questionnaire (for women). Post-delivery questionnaire ....................... 688 1 15/60 172 688 688 1 1 15/60 15/60 172 172 688 1 15/60 172 688 688 4 3 5/60 10/60 229 344 688 3 10/60 344 688 3 10/60 344 688 3 10/60 344 800 688 1 1 5/60 15/60 67 172 688 1 15/60 172 688 688 4 3 5/60 10/60 229 344 688 3 10/60 344 688 1 5/60 57 Total .......................................................................................................................................................................................... 3745 Pregnant women ..... DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4163–18–P mstockstill on PROD1PC66 with NOTICES Dated: January 8, 2009. Maryam I. Daneshvar, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. E9–890 Filed 1–15–09; 8:45 am] Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Member Conflict Review, Program Announcement (PA) 07–318 Centers for Disease Control and Prevention In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date: 1 p.m.–3 p.m., March 5, 2009 (Closed). Place: National Institute for Occupational Safety and Health (NIOSH), CDC, 1095 VerDate Nov<24>2008 19:02 Jan 15, 2009 Jkt 217001 PO 00000 Frm 00059 Fmt 4703 Sfmt 4703 Willowdale Road, Morgantown, West Virginia 26506, telephone: (304) 285–6143. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the review, discussion, and evaluation of ‘‘Member Conflict Review, PA 07–318.’’ Contact Person for More Information: Chris Langub, PhD, Scientific Review Official, NIOSH, CDC, 2400 Century Center, Atlanta, GA 30333, telephone: (404) 498–2543. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. E:\FR\FM\16JAN1.SGM 16JAN1 3050 Federal Register / Vol. 74, No. 11 / Friday, January 16, 2009 / Notices Dated: January 9, 2009. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E9–870 Filed 1–15–09; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Centers for Agricultural Disease and Injury Research, Education and Prevention, Program Announcement Number, PAR06–057 In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: mstockstill on PROD1PC66 with NOTICES Time and Date: 7 p.m.–5 p.m., February 25, 2009 (Closed). 7 p.m.–5 p.m., February 26, 2009 (Closed). 7 p.m.–5 p.m., February 27, 2009 (Closed). Place: Courtyard Greenville, 2225 Stantonsburg Road, Greenville, North Carolina 27834, telephone: (252) 329–2900. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters to be Discussed: The meeting will include the review, discussion, and evaluation of applications received in response to ‘‘Centers for Agricultural Disease and Injury Research, Education and Prevention, PAR06–057.’’ Contact Person for More Information: Stephen Olenchock, PhD, Scientific Review Administrator, 1095 Willowdale Road, Morgantown, West Virginia 26505, telephone: (304) 285–6271. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: January 8, 2009. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E9–873 Filed 1–15–09; 8:45 am] BILLING CODE 4163–18–P VerDate Nov<24>2008 19:02 Jan 15, 2009 Jkt 217001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Centers for Agricultural Disease and Injury Research, Education and Prevention, Program Announcement Number, PAR06–057 In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date: 7 p.m.–5 p.m., February 10, 2009 (Closed). 7 p.m.–5 p.m., February 11, 2009 (Closed). 7 p.m.–5 p.m., February 12, 2009 (Closed). Place: Renaissance Columbus, 50 North 3rd Street, Columbus, Ohio 43215, telephone: (614) 228–5050. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters to be Discussed: The meeting will include the review, discussion, and evaluation of applications received in response to ‘‘Centers for Agricultural Disease and Injury Research, Education and Prevention, PAR06–057.’’ Contact Person for More Information: Stephen Olenchock, PhD, Scientific Review Administrator, 1095 Willowdale Road, Morgantown, West Virginia 26505, telephone: (304) 285–6271. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: January 8, 2009. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E9–874 Filed 1–15–09; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Safety and Occupational Health Study Section (SOHSS), National Institute for Occupational Safety and Health (NIOSH) In accordance with section 10(a)(2) of the Federal Advisory Committee Act PO 00000 Frm 00060 Fmt 4703 Sfmt 4703 (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following Meeting of the aforementioned committee: Times and Dates: 8 a.m.–5 p.m., February 17, 2009. 8 a.m.–5 p.m., February 18, 2009. Place: Embassy Suites Hotel, 1900 Diagonal Road, Alexandria, Virginia 22314, telephone (703)684–5900, fax (703) 684– 1403. Status: Closed 8 a.m.–5 p.m., February 17, 2009. Closed 8 a.m.–5 p.m., February 18, 2009. Purpose: The Safety and Occupational Health Study Section will review, discuss, and evaluate grant application(s) received in response to the Institute’s standard grants review and funding cycles pertaining to research issues in occupational safety and health, and allied areas. It is the intent of NIOSH to support broadbased research endeavors in keeping with the Institute’s program goals. This will lead to improved understanding and appreciation for the magnitude of the aggregate health burden associated with occupational injuries and illnesses, as well as to support more focused research projects, which will lead to improvements in the delivery of occupational safety and health services, and the prevention of work-related injury and illness. It is anticipated that research funded will promote these program goals. Matters To Be Discussed: The meeting will convene to address matters related to the conduct of Study Section business and for the study section to consider safety and occupational health-related grant applications. These portions of the meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, Centers for Disease Control and Prevention, pursuant to Section 10(d) Pub. L. 92–463. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Price Connor, PhD, NIOSH Health Scientist, 1600 Clifton Road, NE., Mailstop E–20, Atlanta, Georgia 30333, telephone (404) 498–2511, fax (404)498–2571. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: January 9, 2009. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E9–872 Filed 1–15–09; 8:45 am] BILLING CODE 4163–18–P E:\FR\FM\16JAN1.SGM 16JAN1

Agencies

[Federal Register Volume 74, Number 11 (Friday, January 16, 2009)]
[Notices]
[Pages 3049-3050]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-870]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Member Conflict Review, Program Announcement (PA) 
07-318

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting:

    Time and Date: 1 p.m.-3 p.m., March 5, 2009 (Closed).
    Place: National Institute for Occupational Safety and Health 
(NIOSH), CDC, 1095 Willowdale Road, Morgantown, West Virginia 26506, 
telephone: (304) 285-6143.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the review, 
discussion, and evaluation of ``Member Conflict Review, PA 07-318.''
    Contact Person for More Information: Chris Langub, PhD, 
Scientific Review Official, NIOSH, CDC, 2400 Century Center, 
Atlanta, GA 30333, telephone: (404) 498-2543.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.


[[Page 3050]]


    Dated: January 9, 2009.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. E9-870 Filed 1-15-09; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.